PI-RADS: what is new and how to use it

Silvina P. Dutruel; Sunil Jeph; Daniel J.A. Margolis; Natasha Wehrli

doi:10.1007/s00261-020-02482-x

PI-RADS: what is new and how to use it

Silvina P. Dutruel, Sunil Jeph, Daniel J.A. Margolis, Natasha Wehrli

Department of Radiology

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

The prostate imaging reporting and data system (PI-RADS) has revolutionized the use of magnetic resonance imaging (MRI) for the management of prostate cancer (PCa). The most recent version 2.1, PI-RADS v2.1, provides specific refinements in the performance, relaxing some recommendations which were not found to be helpful, while reinforcing and clarifying others. The interpretation of T2-weighted imaging (T2WI) in the transition zone (TZ), and the overall assessment of TZ nodules, now allows for a clearer distinction between those which are clearly benign and those which might warrant tissue sampling. Additional changes also resolve discrepancies in T2WI and diffusion-weighted imaging (DWI) of the peripheral zone (PZ). PI-RADS v2.1 is a simpler, more straightforward, and more reproducible method to better communicate between physicians regarding findings on prostate MRI.

Original language	English (US)
Pages (from-to)	3951-3960
Number of pages	10
Journal	Abdominal Radiology
Volume	45
Issue number	12
DOIs	https://doi.org/10.1007/s00261-020-02482-x
State	Published - Dec 2020

All Science Journal Classification (ASJC) codes

Radiological and Ultrasound Technology
Radiology Nuclear Medicine and imaging
Gastroenterology
Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00261-020-02482-x

Cite this

@article{03b9b81ae8374d88ab1dd3bab84f0c07,

title = "PI-RADS: what is new and how to use it",

abstract = "The prostate imaging reporting and data system (PI-RADS) has revolutionized the use of magnetic resonance imaging (MRI) for the management of prostate cancer (PCa). The most recent version 2.1, PI-RADS v2.1, provides specific refinements in the performance, relaxing some recommendations which were not found to be helpful, while reinforcing and clarifying others. The interpretation of T2-weighted imaging (T2WI) in the transition zone (TZ), and the overall assessment of TZ nodules, now allows for a clearer distinction between those which are clearly benign and those which might warrant tissue sampling. Additional changes also resolve discrepancies in T2WI and diffusion-weighted imaging (DWI) of the peripheral zone (PZ). PI-RADS v2.1 is a simpler, more straightforward, and more reproducible method to better communicate between physicians regarding findings on prostate MRI.",

author = "Dutruel, {Silvina P.} and Sunil Jeph and Margolis, {Daniel J.A.} and Natasha Wehrli",

note = "Publisher Copyright: {\textcopyright} 2020, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2020",

month = dec,

doi = "10.1007/s00261-020-02482-x",

language = "English (US)",

volume = "45",

pages = "3951--3960",

journal = "Abdominal Radiology",

issn = "2366-004X",

publisher = "Springer New York",

number = "12",

}

TY - JOUR

T1 - PI-RADS

T2 - what is new and how to use it

AU - Dutruel, Silvina P.

AU - Jeph, Sunil

AU - Margolis, Daniel J.A.

AU - Wehrli, Natasha

PY - 2020/12

Y1 - 2020/12

N2 - The prostate imaging reporting and data system (PI-RADS) has revolutionized the use of magnetic resonance imaging (MRI) for the management of prostate cancer (PCa). The most recent version 2.1, PI-RADS v2.1, provides specific refinements in the performance, relaxing some recommendations which were not found to be helpful, while reinforcing and clarifying others. The interpretation of T2-weighted imaging (T2WI) in the transition zone (TZ), and the overall assessment of TZ nodules, now allows for a clearer distinction between those which are clearly benign and those which might warrant tissue sampling. Additional changes also resolve discrepancies in T2WI and diffusion-weighted imaging (DWI) of the peripheral zone (PZ). PI-RADS v2.1 is a simpler, more straightforward, and more reproducible method to better communicate between physicians regarding findings on prostate MRI.

AB - The prostate imaging reporting and data system (PI-RADS) has revolutionized the use of magnetic resonance imaging (MRI) for the management of prostate cancer (PCa). The most recent version 2.1, PI-RADS v2.1, provides specific refinements in the performance, relaxing some recommendations which were not found to be helpful, while reinforcing and clarifying others. The interpretation of T2-weighted imaging (T2WI) in the transition zone (TZ), and the overall assessment of TZ nodules, now allows for a clearer distinction between those which are clearly benign and those which might warrant tissue sampling. Additional changes also resolve discrepancies in T2WI and diffusion-weighted imaging (DWI) of the peripheral zone (PZ). PI-RADS v2.1 is a simpler, more straightforward, and more reproducible method to better communicate between physicians regarding findings on prostate MRI.

UR - http://www.scopus.com/inward/record.url?scp=85082818601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85082818601&partnerID=8YFLogxK

U2 - 10.1007/s00261-020-02482-x

DO - 10.1007/s00261-020-02482-x

M3 - Article

C2 - 32185445

AN - SCOPUS:85082818601

SN - 2366-004X

VL - 45

SP - 3951

EP - 3960

JO - Abdominal Radiology

JF - Abdominal Radiology

IS - 12

ER -

PI-RADS: what is new and how to use it

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this